Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection

NCT03984747 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT03984747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Completed
Start date
September 14, 2018
Completion date
August 23, 2024
Enrollment
110 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

allograft rejection, complications, transplant rejection